The Drug Regulatory Authority of Pakistan (DRAP) on Tuesday declared one batch of the anti-fever injection PARACET (paracetamol) ‘sub-standard’.
‘Product Recall Alert’ has been issued by the drug regulatory authority in this regard.
DRAP has ordered concerned authorities to immediately seize the sub-standard batch from the markets and ordered the pharmaceutical company to immediately recall the defective batch of product from the market.
The alert states that the batch number CIJI70 of Paracet’s 1g/100ml Infusion was found ‘substandard & adulterated containing black color particles visible to naked eye.”
“All Pharmacists and chemists working at distributions and Pharmacies should immediately check their stocks and stop supplying this batch of product,” it added.
“The remaining stock should be quarantined and returned to the supplier/company. Regulatory field force of all federating units (DRAP, Provincial Health Departments and States) have also increased surveillance in the market to ensure the effective recall of defective product(s),” it read.
Beijing in a statement asserted that attempts to sabotage China-Pakistan cooperation will not succeed and…
Fly Jinnah, Pakistan’s low-cost carrier, on March 27, celebrated the inaugural flight of its second…
Khaie, the story penned by Saqlain Abbas finally concluded with its 29th episode. It was…
Zara Noor Abbas and Asad Siddiqui welcomed their first child on Wednesday. Taking to Instagram,…
Malaysian court is reported to have charged local Mini-Mart Executives over "Allah" written on socks.…
Personal data of 2.7m Pakistanis is reported to have been stolen from the database of…